Search research articles
Contact Us
Filters
Showing results (61-70 of 107) with videos related to
Page
of 11
Sort By:
The Journal of Investigative Dermatology
|
April 2, 2021
Melanoma Differentiation Trajectories Determine Sensitivity toward Pre-Existing CD8<sup>+</sup> Tumor-Infiltrating Lymphocytes
Franziska Noelle Harbers, Beatrice Thier, Simone Stupia, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG
|
October 25, 2025
Exceptional therapeutic benefit of imatinib in cKIT-mutated mucosal melanoma followed by a KIT mutation loss
Hannah Zillikens, Corinna Scheib, Vicky Peller, et al.
European Journal of Cancer (Oxford, England : 1990)
|
August 17, 2019
Clinical and genetic analysis of melanomas arising in acral sites
Anne Zaremba, Rajmohan Murali, Philipp Jansen, et al.
Cancer Research
|
June 5, 2016
Melanoma Lesions Independently Acquire T-cell Resistance during Metastatic Latency
Fang Zhao, Antje Sucker, Susanne Horn, et al.
The Journal of Investigative Dermatology
|
October 26, 2013
SECTM1 produced by tumor cells attracts human monocytes via CD7-mediated activation of the PI3K pathway
Tao Wang, Yingbin Ge, Min Xiao, et al.
Science Translational Medicine
|
December 15, 2015
Metastatic status of sentinel lymph nodes in melanoma determined noninvasively with multispectral optoacoustic imaging
Ingo Stoffels, Stefan Morscher, Iris Helfrich, et al.
Clinical and Translational Medicine
|
November 2, 2022
Circulating cell-free messenger RNA enables non-invasive pan-tumour monitoring of melanoma therapy independent of the mutational genotype
Lea Jessica Albrecht, Anna Höwner, Klaus Griewank, et al.
Clinical and Translational Medicine
|
January 15, 2025
RECQL4 affects MHC class II-mediated signalling and favours an immune-evasive signature that limits response to immune checkpoint inhibitor therapy in patients with malignant melanoma
Sara Egea-Rodriguez, Renáta Váraljai, Thierry M Nordmann, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 18, 2023
HLA Class II Loss and JAK1/2 Deficiency Coevolve in Melanoma Leading to CD4 T-cell and IFNγ Cross-Resistance
Simone Stupia, Christina Heeke, Alicia Brüggemann, et al.
European Journal of Cancer (Oxford, England : 1990)
|
March 31, 2021
Leptomeningeal disease from melanoma-Poor prognosis despite new therapeutic modalities
Eleftheria Chorti, Sied Kebir, Misbah S Ahmed, et al.
Page
of 11
Search research articles
Search
Showing results (61-70 of 107) with videos related to
Sort By:
Page
of 11
The Journal of Investigative Dermatology
|
April 2, 2021
Melanoma Differentiation Trajectories Determine Sensitivity toward Pre-Existing CD8<sup>+</sup> Tumor-Infiltrating Lymphocytes
Franziska Noelle Harbers, Beatrice Thier, Simone Stupia, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG
|
October 25, 2025
Exceptional therapeutic benefit of imatinib in cKIT-mutated mucosal melanoma followed by a KIT mutation loss
Hannah Zillikens, Corinna Scheib, Vicky Peller, et al.
European Journal of Cancer (Oxford, England : 1990)
|
August 17, 2019
Clinical and genetic analysis of melanomas arising in acral sites
Anne Zaremba, Rajmohan Murali, Philipp Jansen, et al.
Cancer Research
|
June 5, 2016
Melanoma Lesions Independently Acquire T-cell Resistance during Metastatic Latency
Fang Zhao, Antje Sucker, Susanne Horn, et al.
The Journal of Investigative Dermatology
|
October 26, 2013
SECTM1 produced by tumor cells attracts human monocytes via CD7-mediated activation of the PI3K pathway
Tao Wang, Yingbin Ge, Min Xiao, et al.
Science Translational Medicine
|
December 15, 2015
Metastatic status of sentinel lymph nodes in melanoma determined noninvasively with multispectral optoacoustic imaging
Ingo Stoffels, Stefan Morscher, Iris Helfrich, et al.
Clinical and Translational Medicine
|
November 2, 2022
Circulating cell-free messenger RNA enables non-invasive pan-tumour monitoring of melanoma therapy independent of the mutational genotype
Lea Jessica Albrecht, Anna Höwner, Klaus Griewank, et al.
Clinical and Translational Medicine
|
January 15, 2025
RECQL4 affects MHC class II-mediated signalling and favours an immune-evasive signature that limits response to immune checkpoint inhibitor therapy in patients with malignant melanoma
Sara Egea-Rodriguez, Renáta Váraljai, Thierry M Nordmann, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 18, 2023
HLA Class II Loss and JAK1/2 Deficiency Coevolve in Melanoma Leading to CD4 T-cell and IFNγ Cross-Resistance
Simone Stupia, Christina Heeke, Alicia Brüggemann, et al.
European Journal of Cancer (Oxford, England : 1990)
|
March 31, 2021
Leptomeningeal disease from melanoma-Poor prognosis despite new therapeutic modalities
Eleftheria Chorti, Sied Kebir, Misbah S Ahmed, et al.
Page
of 11